Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:45 pm Purchase | 2025-06-30 | 13G | TaoWeave, Inc. TWAV | Anson Funds Management LP | 147,055 9.900% | 147,055 (New Position) | Filing History |
| 2025-08-14 9:43 pm Sale | 2025-06-30 | 13G | SELLAS Life Sciences Group, Inc. SLS | Anson Funds Management LP | 5,225,948 4.900% | -2,353,147 (-31.05%) | Filing History |
| 2025-08-14 9:42 pm Purchase | 2025-06-30 | 13G | Applied DNA Sciences, Inc. APDN | Anson Funds Management LP | 573,538 8.200% | 364,069 (+173.81%) | Filing History |
| 2025-08-14 9:41 pm Sale | 2025-06-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 576,482 4.900% | -19,237 (-3.23%) | Filing History |
| 2025-08-14 9:37 pm Purchase | 2025-06-30 | 13G | Nano Labs Ltd NA | Anson Funds Management LP | 1,808,440 8.700% | 1,808,440 (New Position) | Filing History |
| 2025-07-24 3:53 pm Unchanged | 2025-07-22 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 3.700% | 0 (Unchanged) | Filing History |
| 2025-07-14 5:42 pm Sale | 2025-07-11 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 9,057,952 4.200% | -7,303,481 (-44.64%) | Filing History |
| 2025-07-03 6:54 pm Sale | 2025-06-26 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 16,361,433 7.500% | -4,029,780 (-19.76%) | Filing History |
| 2025-05-15 6:07 pm Purchase | 2025-03-31 | 13G | Universe Pharmaceuticals Inc. UPC | Anson Funds Management LP | 234,374 1.000% | 214,816 (+1098.34%) | Filing History |
| 2025-05-15 5:23 pm Purchase | 2025-03-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 595,719 9.900% | 595,538 (+328311.63%) | Filing History |
| 2025-05-15 5:15 pm Purchase | 2025-03-31 | 13G | NRx Pharmaceuticals, Inc. NRXP | Anson Funds Management LP | 1,179,061 7.000% | 1,179,061 (New Position) | Filing History |
| 2025-05-15 5:14 pm Purchase | 2025-03-31 | 13G | Applied DNA Sciences, Inc. APDN | Anson Funds Management LP | 209,469 5.400% | 207,945 (+13643.42%) | Filing History |
| 2025-05-15 5:05 pm Sale | 2025-03-31 | 13G | Tron Inc. TRON | Anson Funds Management LP | 0 0.000% | -1,395,235 (Position Closed) | Filing History |
| 2025-05-15 5:03 pm Purchase | 2025-03-31 | 13G | Sharps Technology, Inc. STSS | Anson Funds Management LP | 1,800,000 9.900% | 1,800,000 (New Position) | Filing History |
| 2025-05-15 4:59 pm Purchase | 2025-03-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | Anson Funds Management LP | 7,579,095 8.300% | 7,579,095 (New Position) | Filing History |
| 2025-05-15 4:57 pm Purchase | 2025-03-31 | 13G | Femto Technologies Inc. FMTOF | Anson Funds Management LP | 324,808 9.900% | 324,808 (New Position) | Filing History |
| 2025-05-15 4:56 pm Purchase | 2025-03-31 | 13G | Color Star Technology Co., Ltd. ADD | Anson Funds Management LP | 225,564 9.900% | 225,564 (New Position) | Filing History |
| 2025-05-15 4:34 pm Purchase | 2025-03-31 | 13G | Cyngn Inc. CYN | Anson Funds Management LP | 77,639 4.200% | 62,837 (+424.53%) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | Greenwave Technology Solutions, Inc. GWAV | Anson Funds Management LP | 44,029 8.000% | 34,643 (+369.11%) | Filing History |
| 2025-05-15 4:21 pm Purchase | 2025-03-31 | 13G | Ethzilla Corp. ETHZ | Anson Funds Management LP | 24,575 4.500% | 2,048 (+9.09%) | Filing History |